Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
#SHAAD debuts Tuesday, August 20. Here’s how you can be part of the Southern Solution.
Black women have a HIV rate 15 times higher than white women.
Final results from the PARTNER 2 study of gay and bi men confirm that undetectable equals untransmittable.
A roundup of POZ’s reporting on studies presented at the Mexico City conference about HIV treatment, vaccines, PrEP and other concerns.
Three counties in the state are among 48 nationwide eligible for federal HIV resources. Here’s what’s fueling new cases in these regions.
Changes to the Title X program concern abortion and target Planned Parenthood. But they should alarm the HIV community.
The chairs of the HIV Medicine Association and the American Academy of HIV Medicine urge health care advice from clinicians, not lawyers.
The PopART study is one of three that have recently reported findings of such programs in sub-Saharan Africa.
How true is his statement? These facts add context.
On-demand, or 2-1-1, PrEP requires taking only four doses of Truvada during the days surrounding sex.
Researchers provided an initial Truvada prescription to eligible gay and bi men and trans women at their first appointment.
Nationwide, significant proportions of PrEP-using populations do not stay on Truvada for long.
A modeling study projected the impact of various strategies for improving PrEP use among young Black gay and bi men in Illinois.
Descovy may offer protection against HIV faster and for longer than Truvada, but its higher cost may outweigh the apparent benefits.
The ASCENT trial found that the vaccine regimen that was advanced to the forthcoming Mosaico trial prompted a strong immune response.
“We’re very happy,” says PAC’s Murray Penner. But he’d like the federal agency to take these additional steps.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.